Cargando…

6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes

Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermed...

Descripción completa

Detalles Bibliográficos
Autores principales: Hofer, Thomas P., van de Loosdrecht, Arjan A., Stahl-Hennig, Christiane, Cassatella, Marco A., Ziegler-Heitbrock, Loems
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753898/
https://www.ncbi.nlm.nih.gov/pubmed/31572354
http://dx.doi.org/10.3389/fimmu.2019.02052
_version_ 1783452983407673344
author Hofer, Thomas P.
van de Loosdrecht, Arjan A.
Stahl-Hennig, Christiane
Cassatella, Marco A.
Ziegler-Heitbrock, Loems
author_facet Hofer, Thomas P.
van de Loosdrecht, Arjan A.
Stahl-Hennig, Christiane
Cassatella, Marco A.
Ziegler-Heitbrock, Loems
author_sort Hofer, Thomas P.
collection PubMed
description Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermediate CD14high monocytes requires setting a gate in what is a gradually changing level of CD14 expression. In the search for an additional marker to better dissect the two subsets we have explored the marker 6-sulfo LacNAc (slan). Slan is a carbohydrate residue originally described to be expressed on the cell surface of a type of dendritic cell in human blood. We elaborate herein that the features of slan+ cells are congruent with the features of CD16+ non-classical monocytes and that slan is a candidate marker for definition of non-classical monocytes. The use of this marker may help in studying the role of non-classical monocytes in health and in diagnosis and monitoring of disease.
format Online
Article
Text
id pubmed-6753898
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-67538982019-09-30 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes Hofer, Thomas P. van de Loosdrecht, Arjan A. Stahl-Hennig, Christiane Cassatella, Marco A. Ziegler-Heitbrock, Loems Front Immunol Immunology Monocytes are subdivided into three subsets, which have different phenotypic and functional characteristics and different roles in inflammation and malignancy. When in man CD14 and CD16 monoclonal antibodies are used to define these subsets, then the distinction of non-classical CD14low and intermediate CD14high monocytes requires setting a gate in what is a gradually changing level of CD14 expression. In the search for an additional marker to better dissect the two subsets we have explored the marker 6-sulfo LacNAc (slan). Slan is a carbohydrate residue originally described to be expressed on the cell surface of a type of dendritic cell in human blood. We elaborate herein that the features of slan+ cells are congruent with the features of CD16+ non-classical monocytes and that slan is a candidate marker for definition of non-classical monocytes. The use of this marker may help in studying the role of non-classical monocytes in health and in diagnosis and monitoring of disease. Frontiers Media S.A. 2019-09-13 /pmc/articles/PMC6753898/ /pubmed/31572354 http://dx.doi.org/10.3389/fimmu.2019.02052 Text en Copyright © 2019 Hofer, van de Loosdrecht, Stahl-Hennig, Cassatella and Ziegler-Heitbrock. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Hofer, Thomas P.
van de Loosdrecht, Arjan A.
Stahl-Hennig, Christiane
Cassatella, Marco A.
Ziegler-Heitbrock, Loems
6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
title 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
title_full 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
title_fullStr 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
title_full_unstemmed 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
title_short 6-Sulfo LacNAc (Slan) as a Marker for Non-classical Monocytes
title_sort 6-sulfo lacnac (slan) as a marker for non-classical monocytes
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6753898/
https://www.ncbi.nlm.nih.gov/pubmed/31572354
http://dx.doi.org/10.3389/fimmu.2019.02052
work_keys_str_mv AT hoferthomasp 6sulfolacnacslanasamarkerfornonclassicalmonocytes
AT vandeloosdrechtarjana 6sulfolacnacslanasamarkerfornonclassicalmonocytes
AT stahlhennigchristiane 6sulfolacnacslanasamarkerfornonclassicalmonocytes
AT cassatellamarcoa 6sulfolacnacslanasamarkerfornonclassicalmonocytes
AT zieglerheitbrockloems 6sulfolacnacslanasamarkerfornonclassicalmonocytes